Breaking Finance News

BTIG announced SeaSpine (NASDAQ:SPNE), boosting its stock price target to $17.00 today

In a report released on Wednesday June 21, 2017 BTIG increased the stock price target of SeaSpine (NASDAQ:SPNE) to $17.00 reporting a possible upside of 0.71%.

Just yesterday SeaSpine (NASDAQ:SPNE) traded 0.10% higher at $9.94. The company’s 50-day moving average is $10.81 and its 200-day moving average is $9.14. The last closing price is up 13.77% relative to the two hundred day average, compared with the Standard & Poor's 500 Index which has increased 0.04% over the same period. Trade Volume was down over the average, with 97,794 shares of SPNE changing hands under the typical 154,680

Recent Performance Chart


SeaSpine has with a one year low of $6.40 and a one year high of $11.40 and has a total market value of $0.

Brief Synopsis About SeaSpine (NASDAQ:SPNE)

SeaSpine Holdings Corporation is a medical technology company. The Company is focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. The Company operates through the development, manufacture and marketing of orthobiologics and spinal fusion hardware segment. It has a portfolio of orthobiologics and spinal fusion hardware solutions to meet the varying combinations of products that neurosurgeons and orthopedic spine surgeons need to perform fusion procedures in the lumbar, thoracic and cervical spine. It offers a portfolio of orthobiologics and spinal fusion hardware products for the treatment of patients suffering from spinal and other orthopedic disorders. Its orthobiologics products consist of a range of bone graft substitutes that are designed to improve bone fusion rates following a range of orthopedic surgeries, including spine, hip and extremities procedures.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.